Evaluation of Efficacy and Safety of Etanercept Therapy in Patients with Early and Late Juvenile Idiopathic Arthritis without Systemic Manifestations

Evaluation of Efficacy and Safety of Etanercept Therapy in Patients with Early and Late Juvenile Idiopathic Arthritis without Systemic Manifestations

Background: An issue related to the terms of assignment of genetically engineered biological agents to patients with juvenile idiopathic arthritis (JIA) still remains debatable in pediatric rheumatology.Objective: Our aim was to evaluate the efficacy and safety of etanercept therapy in early and lat...

Full description

Bibliographic Details
Main Authors: T. M. Bzarova, E. I. Alexeeva, S. I. Valieva, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova, A. M. Chomakhidze, T. V. Sleptsova, A. N. Fetisova, N. I. Taibulatov
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2015-09-01
Series:Вопросы современной педиатрии
Subjects:
дети
ювенильный идиопатический артрит
ранний артрит
поздний артрит
этанерцепт
Online Access:https://vsp.spr-journal.ru/jour/article/view/1079

Internet

https://vsp.spr-journal.ru/jour/article/view/1079

Similar Items